Wikipedia:WikiProject Chemicals/Chembox validation/VerifiedDataSandbox and Mephenesin: Difference between pages
(Difference between pages)
Content deleted Content added
Saving copy of the {{drugbox}} taken from revid 456825480 of page Mephenesin for the Chem/Drugbox validation project (updated: 'CAS_number'). |
Eric Kvaalen (talk | contribs) I don't think it was used to synthesize meprobamate. |
||
Line 1: | Line 1: | ||
{{Short description|Muscle relaxer & antidote for strychnine poisoning}} |
|||
{{ambox | text = This page contains a copy of the infobox ({{tl|drugbox}}) taken from revid [{{fullurl:Mephenesin|oldid=456825480}} 456825480] of page [[Mephenesin]] with values updated to verified values.}} |
|||
{{Drugbox |
{{Drugbox |
||
| Verifiedfields = changed |
| Verifiedfields = changed |
||
| verifiedrevid = |
| verifiedrevid = 462248479 |
||
| IUPAC_name = 3-(2-methylphenoxy)propane-1,2-diol |
| IUPAC_name = 3-(2-methylphenoxy)propane-1,2-diol |
||
| image = Mephenesin.svg |
| image = Mephenesin.svg |
||
Line 11: | Line 11: | ||
| pregnancy_category = |
| pregnancy_category = |
||
| legal_status = |
| legal_status = |
||
| routes_of_administration = |
| routes_of_administration = |
||
<!--Pharmacokinetic data--> |
<!--Pharmacokinetic data--> |
||
| bioavailability = |
| bioavailability = |
||
| metabolism = |
| metabolism = |
||
| excretion = |
| excretion = |
||
<!--Identifiers--> |
<!--Identifiers--> |
||
| CAS_number_Ref = {{cascite| |
| CAS_number_Ref = {{cascite|changed|??}} |
||
| CAS_number = |
| CAS_number = 59-47-2 |
||
| ATC_prefix = M03 |
| ATC_prefix = M03 |
||
| ATC_suffix = BX06 |
| ATC_suffix = BX06 |
||
Line 27: | Line 27: | ||
| ChemSpiderID_Ref = {{chemspidercite|correct|chemspider}} |
| ChemSpiderID_Ref = {{chemspidercite|correct|chemspider}} |
||
| ChemSpiderID = 3919 |
| ChemSpiderID = 3919 |
||
| UNII_Ref = {{fdacite| |
| UNII_Ref = {{fdacite|correct|FDA}} |
||
| UNII = 7B8PIR2954 |
| UNII = 7B8PIR2954 |
||
| KEGG_Ref = {{keggcite|correct|kegg}} |
| KEGG_Ref = {{keggcite|correct|kegg}} |
||
Line 33: | Line 33: | ||
| ChEMBL_Ref = {{ebicite|correct|EBI}} |
| ChEMBL_Ref = {{ebicite|correct|EBI}} |
||
| ChEMBL = 229128 |
| ChEMBL = 229128 |
||
| NIAID_ChemDB = 017830 |
|||
<!--Chemical data--> |
<!--Chemical data--> |
||
| C=10 | H=14 | O=3 |
| C=10 | H=14 | O=3 |
||
| molecular_weight = 182.216 g/mol |
|||
| smiles = O(c1ccccc1C)CC(O)CO |
| smiles = O(c1ccccc1C)CC(O)CO |
||
| InChI = 1/C10H14O3/c1-8-4-2-3-5-10(8)13-7-9(12)6-11/h2-5,9,11-12H,6-7H2,1H3 |
|||
| InChIKey = JWDYCNIAQWPBHD-UHFFFAOYAQ |
|||
| StdInChI_Ref = {{stdinchicite|correct|chemspider}} |
| StdInChI_Ref = {{stdinchicite|correct|chemspider}} |
||
| StdInChI = 1S/C10H14O3/c1-8-4-2-3-5-10(8)13-7-9(12)6-11/h2-5,9,11-12H,6-7H2,1H3 |
| StdInChI = 1S/C10H14O3/c1-8-4-2-3-5-10(8)13-7-9(12)6-11/h2-5,9,11-12H,6-7H2,1H3 |
||
Line 45: | Line 43: | ||
| StdInChIKey = JWDYCNIAQWPBHD-UHFFFAOYSA-N |
| StdInChIKey = JWDYCNIAQWPBHD-UHFFFAOYSA-N |
||
}} |
}} |
||
'''Mephenesin''' ([[International nonproprietary name|INN]]), also called '''myanesin''',<ref>{{cite web |title=Mephenesin Definition & Meaning |url=https://www.merriam-webster.com/medical/mephenesin |website=Merriam-Webster Medical}}</ref><ref name="pmid19108125">{{cite journal | vauthors = Berger FM | title = The mode of action of myanesin | journal = British Journal of Pharmacology and Chemotherapy | volume = 2 | issue = 4 | pages = 241–50 | date = December 1947 | pmid = 19108125 | pmc = 1509790 | doi = 10.1111/j.1476-5381.1947.tb00341.x }}</ref> is a centrally acting [[muscle relaxant]]. It can be used as an [[antidote]] for [[strychnine poisoning]]. Mephenesin however presents with the major drawbacks of having a short duration of action and a much greater effect on the spinal cord than the brain, resulting in pronounced respiratory depression at clinical doses and therefore a very low [[therapeutic index]]. It is especially dangerous and potentially fatal in combination with alcohol and other depressants.<ref>{{cite web|title=Mephenesin|url=https://www.mims.com/USA/drug/info/mephenesin/|publisher=MIMS}}</ref> Mephenesin was the inspiration for the synthesis of a derivative of [[1,3-propanediol]], [[meprobamate]], by Bernard Ludwig and [[Frank Berger]],<ref>{{cite journal | vauthors = Ban TA | title = The role of serendipity in drug discovery | journal = Dialogues in Clinical Neuroscience | volume = 8 | issue = 3 | pages = 335–44 | date = 2006 | pmid = 17117615 | pmc = 3181823 | doi = 10.31887/DCNS.2006.8.3/tban }}</ref> the first tranquilizer to see widespread clinical use. Mephenesin is no longer available in North America but is used in Italy and a few other countries.<ref>{{cite web|title=Mephenesin|url=https://www.drugs.com/international/mephenesin.html|publisher=Drugs.com}}</ref> Its use has largely been replaced by the related drug [[methocarbamol]], which is better absorbed.<ref>{{cite journal|last=Huf|first=Ernst|title=Comparative Plasma Levels of Mephenesin, Mephenesin Carbamate and Methocarbamol|journal=Proceedings of the Society for Experimental Biology and Medicine|year=1959|volume=102|issue=2|pages=276–7|url=http://ebm.sagepub.com/content/102/2/276.abstract|publisher=Experimental Biology & Medicine|doi=10.3181/00379727-102-25218|pmid=14403806|s2cid=37483102|access-date=8 January 2014|display-authors=etal}}</ref> |
|||
Mephenesin may be an [[NMDA receptor antagonist]].<ref name="pmid23825891">{{cite journal | vauthors = Keshavarz M, Showraki A, Emamghoreishi M | title = Anticonvulsant Effect of Guaifenesin against Pentylenetetrazol-Induced Seizure in Mice | journal = Iran J Med Sci | volume = 38 | issue = 2 | pages = 116–21 | year = 2013 | pmid = 23825891 | pmc = 3700057 }}</ref> Mephenesin was previously used in France as an OTC muscle relaxant called Décontractyl but was taken out of production by Sanofi Aventis and due to a French Health Ministry decree in July 2019. Mephenesin is, however, still available in Italy. |
|||
==See also== |
|||
* [[Chlorphenesin]] |
|||
* [[Guaifenesin]] |
|||
* [[Mephenoxalone]] |
|||
* [[Methocarbamol]] |
|||
* [[Prenderol]] |
|||
==External links== |
|||
* {{cite journal |vauthors=Bachmeyer C, Blum L, Fléchet M, Duriez P, Cabane J, Imbert J | title = [Severe contact dermatitis caused by mephenesin] | journal = Ann Dermatol Venereol | volume = 123 | issue = 3 | pages = 185–7 | year = 1996 | pmid = 8761781}} |
|||
* {{cite journal |vauthors=Ono H, Nakamura T, Ito H, Oka J, Fukuda H | title = Rigidity in rats due to radio frequency decerebration and effects of chlorpromazine and mephenesin | journal = Gen Pharmacol | volume = 18 | issue = 1 | pages = 57–9 | year = 1987 | pmid = 3557053 | doi=10.1016/0306-3623(87)90170-4}} |
|||
==References== |
|||
{{Reflist}} |
|||
{{Muscle relaxants}} |
|||
[[Category:Diols]] |
|||
[[Category:Drugs with unknown mechanisms of action]] |
|||
[[Category:Muscle relaxants]] |
|||
[[Category:Phenol ethers]] |
|||
{{musculoskeletal-drug-stub}} |